基因重组糖蛋白CD44s的N-糖基化研究及其被LSECtin识别机理的初步探索
|
摘要
CD44是分布极为广泛的细胞表面跨膜糖蛋白,参与细胞的许多生理过程,包括生长调控,存活,分化和迁移等。CD44表达量的变化以及功能的异常会导致机体的很多病理变化。CD44与胞外基质中的透明质酸、层粘连蛋白等基质分子之间的相互作用使得CD44能够介导异质性粘附,如肿瘤细胞与宿主细胞及宿主基质的粘附。异质性粘附在肿瘤细胞侵袭转移中起促进作用,因此有大量的研究认为CD44与肿瘤侵润转移有关。
CD44s是CD44蛋白家族中分子量最小,仅含有组成性外显子的成员,广泛分布在脊椎动物发育及成熟的各种器官中。近年来,越来越多的研究开始关注糖基化对CD44s与其配体之间相互作用的调控。CD44最重要的功能是能够与透明质酸发生结合,两者间的结合参与肿瘤转移进程中的解粘附、迁移、粘附、入侵过程中的多个步骤。阻止二者之间的相互作用能够抑制原发性肿瘤的生长和转移。越来越多的研究发现CD44s的N-糖基化状态是调控其与透明质酸间结合的重要机制。新的研究发现CD44s是L-选凝素、P-选凝素和纤维蛋白原等能够介导细胞间异质性粘附的分子的内源性配体,并且这些相互作用都受到CD44s N-糖基化状态的调控。但是目前对CD44s的N-糖基化修饰,包括修饰位点、修饰类型及其糖型的微不均一性等均未见文献报道。
LSECtin是一种在肝脏和淋巴结窦状细胞中高表达的C-型凝集素,其特殊的定位暗示着它在这些细胞中发挥重要的作用。目前的研究表明,LSECtin与多种病毒表面糖蛋白之间的相互作用是造成这些病毒在肝脏和淋巴结聚集、感染的原因之一。最新的研究发现LSECtin能够识别乳腺癌细胞上的CD44s的N-糖链。已有研究表明,乳腺癌细胞在发生转移时多数是转移到对侧的淋巴结内皮细胞上。由此,我们推测LSECtin作为一种特异高表达在淋巴结窦内皮细胞上的粘附分子,可能参与了乳腺癌细胞的淋巴结转移,而这个事件的分子基础可能是LSECtin对乳腺癌细胞上CD44s的特殊糖链结构的识别。对CD44s N-糖基化修饰的研究将为探索此事件的发生机制奠定基础。
糖基化修饰是最普遍的蛋白质翻译后修饰形式之一。然而对蛋白质糖基化修饰的研究远远落后于对蛋白质本身的研究,这主要是由于糖基化修饰的发生没有模板指导,在多种糖基转移酶和糖苷酶的作用下,即使同一个糖基化位点上也会存在多种多样的糖基化修饰,即微不均一性,大大增加了分析的复杂性。糖链结构本身的特点决定了其没有紫外吸收,在质谱中的响应信号强度远不如肽段。因此糖基化修饰的鉴定过程常需要对糖链进行衍生化或对糖肽进行富集,反应过程复杂且步骤繁多,尤其是在糖蛋白可获得的量比较少的情况下,对其糖基化的分析尤为困难。
本文首先对NS0细胞重组表达的CD44s的N-糖基化修饰做了全面、细致的研究。采用PNGase F酶切结合18O标记N-糖基化位点-液质联用检测的方法确定重组CD44s的5个潜在的N-糖基化位点均发生了糖基化,并确定了各个N-糖基化位点发生修饰的程度。用PNGase F将其N-聚糖切除,并通过泛甲基化修饰-MALDI-TOF质谱检测和2-AB标记-Q-TOF质谱检测两种方法,得到了其N-糖分布总谱及各种糖型的相对含量。利用亲水色谱结合Q-TOF质谱检测对CD44s的酶切肽段进行分析,最终得到CD44s各个N-糖基化位点上的糖型分布。其中第5位天冬酰胺上分布的糖型主要是二三天线的复合型,少部分发生了核心岩藻糖基化,部分结构末端有唾液酸修饰。第37,80和90位天冬酰胺上分布的糖型主要是二三天线的复合型,全部发生了核心岩藻糖基化,部分结构末端有唾液酸修饰。第100位天冬酰胺上分布的糖型主要是未发生岩藻糖基化的高甘露糖型。上述研究首次对CD44s的N-糖基化作了全面系统的分析,为深入理解CD44s N-糖基化的生理功能提供了基础。
在对CD44s的N-糖基化修饰全面系统分析的基础上,本研究对LSECtin识别CD44s N-糖链的分子机理做了初步探索。通过亲和捕获-质谱鉴定的方法初步确定第80位天冬酰胺上的糖链是LSECtin识别的关键部位,对此结果进行了N-糖基化位点突变的验证,结果显示该位点的突变确实会导致两者之间相互作用的减弱。根据LSECtin特异识别的糖型结构的特点,对CD44s蛋白进行三种糖苷外切酶的酶切,用ELISA检测验证CD44s酶切产物与LSECtin之间的相互作用,结果显示LSECtin与CD44s之间的相互作用依赖于CD44s末端的N-乙酰葡萄糖胺,与文献所报道的LSEctin的糖型识别特点一致。蛋白质三维结构研究的报道也证明,其80位天冬酰胺处在CD44三维结构中较有利于与其他分子发生相互作用的位置。上述研究结果首次揭示了LSECtin与CD44s之间相互作用的分子结构基础,对深入理解LSECtin与乳腺癌的识别机制具有重要意义,并为研发阻断乳腺癌转移的药物提供了新的思路。
有文献报道证明不同哺乳动物细胞中表达的重组蛋白的糖链结构和糖型分布会有所不同,而CHO(Chinese hamster ovary,中国仓鼠卵巢)细胞重组表达的CD44s也具有与LSECtin发生相互作用的功能。因此,本文对CHO细胞重组表达的CD44s的N-糖基化也进行了分析,并比较了NS0和CHO细胞中表达的CD44s N-糖基化的区别。我们发现NS0细胞中合成的N-糖中发生核心岩藻糖基化的糖链个数多于CHO细胞;NS0细胞中的半乳糖均是以α键连接在糖链中,而CHO细胞中则是以β键连接;两种细胞中的糖链末端都存在NeuGc的结构,CHO细胞中还存在NeuAc。两种细胞中表达CD44s上N-糖的差异,从侧面证明LSECtin与CD44s之间的结合不依赖于半乳糖、NeuGc或NeuAc。
为了解决糖蛋白质组研究中糖链在质谱中检测灵敏度低的问题,本研究还发展了一种对N-聚糖进行快速标记结合质谱检测的新方法。采用酰肼活性基团对中性N-聚糖进行标记,使其在MALDI-TOF质谱中检测的灵敏度提高了10倍。对葡聚糖、去唾液酸化胎球蛋白以及CHO细胞中表达的CD44s的N-糖链质谱分析表明,该方法快速、简便,不需要后处理,特别适用于糖蛋白样品量较少时的分析。
CD44 proteins are class I transmembrane glycoproteins mediating the response of cells to their cellular microenvironment. CD44 proteins participate in many cellular processes, including the regulation of growth, survival, differentiation and motility. The altered expression or dysfunction of CD44 proteins contributes to numerous pathological conditions. The adhesive qualities of the CD44 can lead to interaction between two different cells or between a cell and its pericellular matrix. CD44 mediates cell-cell and cell-matrix interactions, in large part through its affinity for hyaluronan (HA), a glycosaminoglycan of extracellular matrices (ECMs), but also potentially through its affinity for other ligands such as osteopontin, collagens. Furthermore the interaction of CD44 with these cellular proteins involved in motogenesis and proteolysis is a determinant factor in cell migration and invasion. The smallest CD44 isoform, which is known as CD44 standard (CD44s), is ubiquitously expressed in vertebrates in developing and adult organisms. The mRNA of this isoform contains no variant exons. Recently, more and more studies found the N-glycosylation of CD44s was involved in the regulation of its function. One primary function of CD44 is binding to HA. Metastasis is a multistep process that includes de-adhesion, migration, adhesion, and invasion. CD44 and its specific interaction with HA have been implicated in many of these processes. Reagents blocking the CD44/HA interaction have been found to prevent primary tumor growth and metastasis. Moreover, recent evidence suggests that glycosylation may be a major mechanism controlling the interaction between CD44 and HA. Some studies also reported that the N-glycosylation of CD44s is associated with the interaction between CD44s and L-selectin, P-selectin, fibrin (ogen). However, the glycosylation situation of CD44s including the types of the glycans, the sites occupancy of the glycosylation has never been comprehensively studied before.
LSECtin is a member of the C-type lectins that is found predominantly on sinusoidal endothelial cells of the liver and lymph nodes, suggesting that it plays a specific role in these cells. It was reported that the interaction between LSECtin and glycoproteins on some kind of virus may concentrate certain viral pathogens in liver and lymph nodes and augment infectious. Recent study found that LSECtin can recognize the N-glycan of CD44s on breast cancer cells. A large number of studies show that breast cancer cells will metastasize to endothelial cells of lymph node on the opposite side. So it was spectulated that the recognition between LSECtin and CD44s may play an important role in the tumor metastasis from breast to lymph node, and the specific glycoform of CD44s is the keypoint of the recognition. In order to study the mechanism of the incident, comprehensive characterization of the N-glycosylation of CD44s is fundamental and very important.
Glycosylation is one of most common post-translational modification. But the study of glycosylatin is lagged far behind the analysis of protein. It is because their biosynthesis occurs in a non-template controlled manner and mature structures arise through the activities of a series of enzymatic reactions. So the glycans on one site are mixtures of variants (named microheterogeneity), which makes the analysis for them very complicated. The characteristics of glycan structure determine that they do not have UV absorption, and have lower response in the mass spectrometry than peptides. So the derivatization of glycan or enrichment of glycopeptides before MS analysis should be carried on in the analysis of glycosylation. The process is multistep and complicated, especially in the situation of the available amount of samples is little, the analysis of its glycosylation is particularly difficult.
In this thesis, the N-glycosylation of CD44s expressed in NS0 cells was characterized completely for the first time. We used the PNGase F deglycosylation in H218O to label the N-glycosylation sites and then analyzed the peptides and glycopeptides by LC-LTQ MS. As a result, all five predicted N-glycosylation sites were confirmed to be occupied by an oligosaccharide moiety. Then the N-glycans released by PNGase F digestion were analyzed by permethylation-MALDI-TOF MS and 2-AB labeled-ESI-Q-TOF MS. The profile of CD44s’N-glycans and the relative quantity were obtained. The glycopeptides and peptides of CD44s were separated by HILIC-UPLC system at the peptide level and detected online by a Q-TOF mass spectrometer to identify the information of site heterogeneity. The glycoforms on Asn5 are bi-, and triantennary complex type, little with fucose and NeuGc. The glycoforms on Asn37, Asn80 and Asn90 are also bi-, and triantennary complex type, all of them are core fucoslated, some structure carrying sialic acid. On Asn100, there are high mannose type structures having from five to seven mannose residues and no core fucosylation. A comprehensive study on the glycosylation status of CD44s was performed for the first time, which will facilitate future understanding about the roles of oligosaccharides from CD44s in related biological process.
On the basis of completely characterization of CD44s’glycosylation, we made preliminary studies on the structure bases of the recognition between LSECtin and CD44s. We used the immbolized LSECtin to capture the specific glycopeptides of CD44s which was then detected by the LTQ-MS. The results showed that the Asn80 is the very important site recognized by LSECtin. The result was first validated by the mutation of N-glycosylation sites. When Asn80 was mutated to Ser, the interaction between the LSECtin and CD44s decreased clearly. It was reported that LSECtin can bind to GlcNAc-1-2Man with very high affinity. Then we treated the CD44s with three exoglycosidases and detected the interaction with LSECtin by ELISA. The results showed that the GlcNAc at the terminal of the glycan play the important role in the interaction between LSECtin and CD44s. The analysis of three dimentaional structure of CD44s reported by reference also indicated that the Asn80 is in a palce that can interact with other molecular easily. These findings have the important research significance in the understanding the mechanism of the recognition between LSECtin and CD44s. And it may provide new perspective to develope the drug to repress the metastasis of breast cancer.
The N-glycosylatin of the CD44s expressed in CHO cells was also analyzed by the same way above. All five consensus sequences for N-glycosylation were found to be glycosylated. The profile of CD44s’N-glycans are detected by permethylation- MALDI-TOF MS and exoglycosidase treatment. The glycan forms of CD44s expressed in NS0 and CHO cells are compared. The glycans in NS0 cells are more fucosylated than in CHO cells. There are Gal (α1-3) Gal in NS0 cells andβform in CHO cell just like in human cells. They all have NeuGc in glycans, which is NeuAc in human cells. The differences of N-glycans between the two cells confirmed our deduction that recognition between the LSECtin and CD44s was not affected by the amount of fucose, linkage form of Gal, type of sialic acid.
To solve the widespread problem in glycoproteomics studies, such as lower response of the glycan in mass spectrometry, a rapid and convenient derivatization method of oligosaccharides was developed. The hydrazones were generated by the reaction of the reducing ends of oligosaccharides and the hydrazide of CPH. The derivatives can be directly analyzed by MALDI-TOF-MS without any treatment. An approximately 10-fold increase in detection sensitivity was observed. The new developed method was applied to the analysis of N-glycans on CD44s expressed in CHO cells and satisfactory results were obtained. The method can be used to analyze the N-glycans of glycoprotein especially when only small amount of sample is available.
CD44s是CD44蛋白家族中分子量最小,仅含有组成性外显子的成员,广泛分布在脊椎动物发育及成熟的各种器官中。近年来,越来越多的研究开始关注糖基化对CD44s与其配体之间相互作用的调控。CD44最重要的功能是能够与透明质酸发生结合,两者间的结合参与肿瘤转移进程中的解粘附、迁移、粘附、入侵过程中的多个步骤。阻止二者之间的相互作用能够抑制原发性肿瘤的生长和转移。越来越多的研究发现CD44s的N-糖基化状态是调控其与透明质酸间结合的重要机制。新的研究发现CD44s是L-选凝素、P-选凝素和纤维蛋白原等能够介导细胞间异质性粘附的分子的内源性配体,并且这些相互作用都受到CD44s N-糖基化状态的调控。但是目前对CD44s的N-糖基化修饰,包括修饰位点、修饰类型及其糖型的微不均一性等均未见文献报道。
LSECtin是一种在肝脏和淋巴结窦状细胞中高表达的C-型凝集素,其特殊的定位暗示着它在这些细胞中发挥重要的作用。目前的研究表明,LSECtin与多种病毒表面糖蛋白之间的相互作用是造成这些病毒在肝脏和淋巴结聚集、感染的原因之一。最新的研究发现LSECtin能够识别乳腺癌细胞上的CD44s的N-糖链。已有研究表明,乳腺癌细胞在发生转移时多数是转移到对侧的淋巴结内皮细胞上。由此,我们推测LSECtin作为一种特异高表达在淋巴结窦内皮细胞上的粘附分子,可能参与了乳腺癌细胞的淋巴结转移,而这个事件的分子基础可能是LSECtin对乳腺癌细胞上CD44s的特殊糖链结构的识别。对CD44s N-糖基化修饰的研究将为探索此事件的发生机制奠定基础。
糖基化修饰是最普遍的蛋白质翻译后修饰形式之一。然而对蛋白质糖基化修饰的研究远远落后于对蛋白质本身的研究,这主要是由于糖基化修饰的发生没有模板指导,在多种糖基转移酶和糖苷酶的作用下,即使同一个糖基化位点上也会存在多种多样的糖基化修饰,即微不均一性,大大增加了分析的复杂性。糖链结构本身的特点决定了其没有紫外吸收,在质谱中的响应信号强度远不如肽段。因此糖基化修饰的鉴定过程常需要对糖链进行衍生化或对糖肽进行富集,反应过程复杂且步骤繁多,尤其是在糖蛋白可获得的量比较少的情况下,对其糖基化的分析尤为困难。
本文首先对NS0细胞重组表达的CD44s的N-糖基化修饰做了全面、细致的研究。采用PNGase F酶切结合18O标记N-糖基化位点-液质联用检测的方法确定重组CD44s的5个潜在的N-糖基化位点均发生了糖基化,并确定了各个N-糖基化位点发生修饰的程度。用PNGase F将其N-聚糖切除,并通过泛甲基化修饰-MALDI-TOF质谱检测和2-AB标记-Q-TOF质谱检测两种方法,得到了其N-糖分布总谱及各种糖型的相对含量。利用亲水色谱结合Q-TOF质谱检测对CD44s的酶切肽段进行分析,最终得到CD44s各个N-糖基化位点上的糖型分布。其中第5位天冬酰胺上分布的糖型主要是二三天线的复合型,少部分发生了核心岩藻糖基化,部分结构末端有唾液酸修饰。第37,80和90位天冬酰胺上分布的糖型主要是二三天线的复合型,全部发生了核心岩藻糖基化,部分结构末端有唾液酸修饰。第100位天冬酰胺上分布的糖型主要是未发生岩藻糖基化的高甘露糖型。上述研究首次对CD44s的N-糖基化作了全面系统的分析,为深入理解CD44s N-糖基化的生理功能提供了基础。
在对CD44s的N-糖基化修饰全面系统分析的基础上,本研究对LSECtin识别CD44s N-糖链的分子机理做了初步探索。通过亲和捕获-质谱鉴定的方法初步确定第80位天冬酰胺上的糖链是LSECtin识别的关键部位,对此结果进行了N-糖基化位点突变的验证,结果显示该位点的突变确实会导致两者之间相互作用的减弱。根据LSECtin特异识别的糖型结构的特点,对CD44s蛋白进行三种糖苷外切酶的酶切,用ELISA检测验证CD44s酶切产物与LSECtin之间的相互作用,结果显示LSECtin与CD44s之间的相互作用依赖于CD44s末端的N-乙酰葡萄糖胺,与文献所报道的LSEctin的糖型识别特点一致。蛋白质三维结构研究的报道也证明,其80位天冬酰胺处在CD44三维结构中较有利于与其他分子发生相互作用的位置。上述研究结果首次揭示了LSECtin与CD44s之间相互作用的分子结构基础,对深入理解LSECtin与乳腺癌的识别机制具有重要意义,并为研发阻断乳腺癌转移的药物提供了新的思路。
有文献报道证明不同哺乳动物细胞中表达的重组蛋白的糖链结构和糖型分布会有所不同,而CHO(Chinese hamster ovary,中国仓鼠卵巢)细胞重组表达的CD44s也具有与LSECtin发生相互作用的功能。因此,本文对CHO细胞重组表达的CD44s的N-糖基化也进行了分析,并比较了NS0和CHO细胞中表达的CD44s N-糖基化的区别。我们发现NS0细胞中合成的N-糖中发生核心岩藻糖基化的糖链个数多于CHO细胞;NS0细胞中的半乳糖均是以α键连接在糖链中,而CHO细胞中则是以β键连接;两种细胞中的糖链末端都存在NeuGc的结构,CHO细胞中还存在NeuAc。两种细胞中表达CD44s上N-糖的差异,从侧面证明LSECtin与CD44s之间的结合不依赖于半乳糖、NeuGc或NeuAc。
为了解决糖蛋白质组研究中糖链在质谱中检测灵敏度低的问题,本研究还发展了一种对N-聚糖进行快速标记结合质谱检测的新方法。采用酰肼活性基团对中性N-聚糖进行标记,使其在MALDI-TOF质谱中检测的灵敏度提高了10倍。对葡聚糖、去唾液酸化胎球蛋白以及CHO细胞中表达的CD44s的N-糖链质谱分析表明,该方法快速、简便,不需要后处理,特别适用于糖蛋白样品量较少时的分析。
CD44 proteins are class I transmembrane glycoproteins mediating the response of cells to their cellular microenvironment. CD44 proteins participate in many cellular processes, including the regulation of growth, survival, differentiation and motility. The altered expression or dysfunction of CD44 proteins contributes to numerous pathological conditions. The adhesive qualities of the CD44 can lead to interaction between two different cells or between a cell and its pericellular matrix. CD44 mediates cell-cell and cell-matrix interactions, in large part through its affinity for hyaluronan (HA), a glycosaminoglycan of extracellular matrices (ECMs), but also potentially through its affinity for other ligands such as osteopontin, collagens. Furthermore the interaction of CD44 with these cellular proteins involved in motogenesis and proteolysis is a determinant factor in cell migration and invasion. The smallest CD44 isoform, which is known as CD44 standard (CD44s), is ubiquitously expressed in vertebrates in developing and adult organisms. The mRNA of this isoform contains no variant exons. Recently, more and more studies found the N-glycosylation of CD44s was involved in the regulation of its function. One primary function of CD44 is binding to HA. Metastasis is a multistep process that includes de-adhesion, migration, adhesion, and invasion. CD44 and its specific interaction with HA have been implicated in many of these processes. Reagents blocking the CD44/HA interaction have been found to prevent primary tumor growth and metastasis. Moreover, recent evidence suggests that glycosylation may be a major mechanism controlling the interaction between CD44 and HA. Some studies also reported that the N-glycosylation of CD44s is associated with the interaction between CD44s and L-selectin, P-selectin, fibrin (ogen). However, the glycosylation situation of CD44s including the types of the glycans, the sites occupancy of the glycosylation has never been comprehensively studied before.
LSECtin is a member of the C-type lectins that is found predominantly on sinusoidal endothelial cells of the liver and lymph nodes, suggesting that it plays a specific role in these cells. It was reported that the interaction between LSECtin and glycoproteins on some kind of virus may concentrate certain viral pathogens in liver and lymph nodes and augment infectious. Recent study found that LSECtin can recognize the N-glycan of CD44s on breast cancer cells. A large number of studies show that breast cancer cells will metastasize to endothelial cells of lymph node on the opposite side. So it was spectulated that the recognition between LSECtin and CD44s may play an important role in the tumor metastasis from breast to lymph node, and the specific glycoform of CD44s is the keypoint of the recognition. In order to study the mechanism of the incident, comprehensive characterization of the N-glycosylation of CD44s is fundamental and very important.
Glycosylation is one of most common post-translational modification. But the study of glycosylatin is lagged far behind the analysis of protein. It is because their biosynthesis occurs in a non-template controlled manner and mature structures arise through the activities of a series of enzymatic reactions. So the glycans on one site are mixtures of variants (named microheterogeneity), which makes the analysis for them very complicated. The characteristics of glycan structure determine that they do not have UV absorption, and have lower response in the mass spectrometry than peptides. So the derivatization of glycan or enrichment of glycopeptides before MS analysis should be carried on in the analysis of glycosylation. The process is multistep and complicated, especially in the situation of the available amount of samples is little, the analysis of its glycosylation is particularly difficult.
In this thesis, the N-glycosylation of CD44s expressed in NS0 cells was characterized completely for the first time. We used the PNGase F deglycosylation in H218O to label the N-glycosylation sites and then analyzed the peptides and glycopeptides by LC-LTQ MS. As a result, all five predicted N-glycosylation sites were confirmed to be occupied by an oligosaccharide moiety. Then the N-glycans released by PNGase F digestion were analyzed by permethylation-MALDI-TOF MS and 2-AB labeled-ESI-Q-TOF MS. The profile of CD44s’N-glycans and the relative quantity were obtained. The glycopeptides and peptides of CD44s were separated by HILIC-UPLC system at the peptide level and detected online by a Q-TOF mass spectrometer to identify the information of site heterogeneity. The glycoforms on Asn5 are bi-, and triantennary complex type, little with fucose and NeuGc. The glycoforms on Asn37, Asn80 and Asn90 are also bi-, and triantennary complex type, all of them are core fucoslated, some structure carrying sialic acid. On Asn100, there are high mannose type structures having from five to seven mannose residues and no core fucosylation. A comprehensive study on the glycosylation status of CD44s was performed for the first time, which will facilitate future understanding about the roles of oligosaccharides from CD44s in related biological process.
On the basis of completely characterization of CD44s’glycosylation, we made preliminary studies on the structure bases of the recognition between LSECtin and CD44s. We used the immbolized LSECtin to capture the specific glycopeptides of CD44s which was then detected by the LTQ-MS. The results showed that the Asn80 is the very important site recognized by LSECtin. The result was first validated by the mutation of N-glycosylation sites. When Asn80 was mutated to Ser, the interaction between the LSECtin and CD44s decreased clearly. It was reported that LSECtin can bind to GlcNAc-1-2Man with very high affinity. Then we treated the CD44s with three exoglycosidases and detected the interaction with LSECtin by ELISA. The results showed that the GlcNAc at the terminal of the glycan play the important role in the interaction between LSECtin and CD44s. The analysis of three dimentaional structure of CD44s reported by reference also indicated that the Asn80 is in a palce that can interact with other molecular easily. These findings have the important research significance in the understanding the mechanism of the recognition between LSECtin and CD44s. And it may provide new perspective to develope the drug to repress the metastasis of breast cancer.
The N-glycosylatin of the CD44s expressed in CHO cells was also analyzed by the same way above. All five consensus sequences for N-glycosylation were found to be glycosylated. The profile of CD44s’N-glycans are detected by permethylation- MALDI-TOF MS and exoglycosidase treatment. The glycan forms of CD44s expressed in NS0 and CHO cells are compared. The glycans in NS0 cells are more fucosylated than in CHO cells. There are Gal (α1-3) Gal in NS0 cells andβform in CHO cell just like in human cells. They all have NeuGc in glycans, which is NeuAc in human cells. The differences of N-glycans between the two cells confirmed our deduction that recognition between the LSECtin and CD44s was not affected by the amount of fucose, linkage form of Gal, type of sialic acid.
To solve the widespread problem in glycoproteomics studies, such as lower response of the glycan in mass spectrometry, a rapid and convenient derivatization method of oligosaccharides was developed. The hydrazones were generated by the reaction of the reducing ends of oligosaccharides and the hydrazide of CPH. The derivatives can be directly analyzed by MALDI-TOF-MS without any treatment. An approximately 10-fold increase in detection sensitivity was observed. The new developed method was applied to the analysis of N-glycans on CD44s expressed in CHO cells and satisfactory results were obtained. The method can be used to analyze the N-glycans of glycoprotein especially when only small amount of sample is available.
引文
[1]Naor D, Sionov R V, Ish-Shalom D. in Advances in Cancer Research Vol. 70 (eds Vande Woude, G. F. & Klein, G.) 243–318 ,1997.
[2]Borland, G., Ross, J. A. & Guy, K. Forms and functions of CD44. Immunology 93, 139–148 (1998).
[3]Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003,4(1):33-45.
[4]Katoh S, Zheng Z, Oritani K. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995, 182(2), 419–429.
[5]Katoh S, Miyagi T, Taniguchi H, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol. 1999, 162(9), 5058-5061.
[6]Lesley J, English N, Perschl A, et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med. 1995, 182(2), 431-437.
[7]English NM, Lesley JF, Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 1998, 58(16), 3736-3742.
[8]Bartolazzi A, Nocks A, Aruffo A, Spring F, et al. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol. 1996 , 132(6),1199-1208.
[9] Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 1998, 140(2), 431–446.
[10]Dimitroff CJ, Lee JY, Fuhlbrigge RC, et al.A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S A. 2000, 97(25), 13841-13846.
[11]Hanley WD, Napier SL, Burdick MM, et al. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J. 2006, 20(2):337-9.
[12]Alves CS, Yakovlev S, Medved L,et al. Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J Biol Chem. 2009, 284(2), 1177-1189.
[13]Liu W, Tang L, Zhang G, et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem. 2004, 279(18),18748-18758.
[14]Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, et al. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood. 2007, 109(12), 5337-5345.
[15]Domínguez-Soto A, Aragoneses-Fenoll L, Gómez-Aguado F, et al. The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1.Hepatology, 2009, 49 (1), 287-296.
[16]Powlesland AS, Fisch T, Taylor ME, et al. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem. 2008, 283(1), 593-602.
[17] Gramberg T, Hofmann H, M?ller P, et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology. 2005, 340(2), 224-236.
[18] Tang L, Yang J, Tang X, et al. The DC-SIGN family member LSECtin is a novel ligand of CD44 on activated T cells. Eur J Immunol. 2010, 40(4), 1185-1191.
[19]Rudd PM. Oligosaccharides in human biology. Glyco News. 1993, 3, 1–8.
[20]Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta.1999, 1473(1), 4–8.
[21]Hagglund P, Bunkenborg J, Elortza F, et al. A new strategy for identification of I-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res.2004, 3(3), 556–566.
[22]Kameyama A, Nakaya S, Ito H, et al. Strategy for simulation of CID spectra of N-linked oligosaccharides towards glycomics. J Proteome Res.2006, 5, 808–814.
[23]Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007, 446, 1023–1029.
[24] Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006, 126, 855–867.
[25]Dall’Olio F. Protein glycosylation in cancer biology:an overview. Clin Mol Pathol. 1996, 49(3), M126–M135.
[26]Fukuda M. Possible roles of tumour associated carbohydrate antigens. Cancer Research. 1996, 56, 2237–2244.
[27]Brooks SA. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol Histopathol. 2000, 15, 143–158.
[28]Dube DH, Bertozzi CR. Glycans in cancer and inflammation–potential for therapeutics and diagnostics. Nat Rev Drug Discov. 2005, 4(6), 477–488.
[29]Van den Eijnden DH, Joziasse DH. Enzymes associated with glycosylation. Curr Opin Struct Biol. 1993, 3(5), 711–721.
[30]Dwek RA. Glycobiology: Toward the understanding of the function of sugars. Chemical Reviews. 1996, 96(2), 683–720.
[31]Joseph Zaia. Mass Spectrometry and the Emerging Field of Glycomics, Chem Biol. 2008,15(9), 881–892.
[32]Von der Lieth CW, Bohne-Lang A, Lohmann KK., et al. Bioinformatics for glycomics: status, methods, requirements and perspectives. Brief Bioinform. 2004, 5(2),164-178.
[33]Hirabayashi J, Hayama K, Kaji H, et al. Affinity capturing and gene assignment of soluble glycoproteins produced by the nematode Caenorhabditis elegansv. J Biochem (Tokyo). 2002, 132(1), 103-114.
[34]Dell A, Morris HR, Glycoprotein structure determination by mass spectrometry. Science. 2001, 291(5512), 2351-2356.
[35]Brooks SA, Hall DM, Buley I. GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane. Br J Cancer. 2001,85(7),1014-1022.
[36]Hart C, Schulenberg B, Steinberg TH, et al. Detection of glycoproteins in polyacrylamide gels and on electroblots using Pro-Q Emerald 488 dye, a fluorescent periodate Schiff-base stain. Electrophoresis. 2003, 24(4),588-598.
[37]Osborne C, Brooks SA. SDS-PAGE and Western blotting to detect proteins and glycoproteins of interest in breast cancer research. Methods Mol Med. 2006,120, 217-229.
[38]Wilson NL, Schulz BL, Karlsson NG, et al.Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res. 2002 ,1(6),521-529.
[39]Dwek MV, Rawlings SL. Current perspectives in cancer proteomics. Mol Biotechnol. 2002, 22(2),139-152.
[40]Dwek MV, Alaiya AA. Proteome analysis enables separate clustering of normalbreast, benign breast and breast cancer tissues. Br J Cancer, 2003, 89(2),305–307.
[41] Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005, 102(3), 779–784.
[42]Rudd PM, Colominas C, Royle L, et al. A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands. Proteomics. 2001, 1(2), 285–294.
[43] Rudiger H, Gabius HJ. Plant lectins: Occurrence, biochemistry, functions and applications. Glycoconj J.2001, 18(8), 589–613.
[44]Sharon N, Lis H. History of lectins: From hemagglutinins to biological recognition molecules. Glycobiology. 2004, 14(11), 53–62.
[45]Bunkenborg J, Pilch BJ, Podtelejnikov AV, et al. Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics. 2004, 4(2), 454-465.
[46]Hirabayashi J, Arata Y, Kasai K. Glycome project: concept, strategy and preliminary application to Caenorhabditis elegans. Proteomics. 2001, 1(2), 295-303.
[47]Hirabayashi J, Hashidate T, Kasai K. Glyco-catch method: A lectin affinity technique for glycoproteomics. J Biomol Tech. 2002, 13, 205-218.
[48]Hirabayashi J, Kasai K. Separation technologies for glycomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2002, 771(1-2), 67-87.
[49]Kaji H, Saito H, Yamauchi Y, et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol. 2003, 21(6), 667-672.
[50]Zhao J, Simeone DM, Heidt D, et al. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J Proteome Res. 2006, 5(7), 1792-1802.
[51]Kreunin P, Zhao J, Rosser C, et al. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res. 2007, 6(7), 2631-2639.
[52]Pan S, Wang Y, Quinn JF, et al. Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J Proteome Res. 2006, 5(10), 2769-2779.
[53]Lewandrowski U, Moebius J, Walter U, et al. Elucidation of N-glycosylation siteson human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics. 2006, 5(2), 226-233
[54]Sun B, Ranish JA, Utleg AG, et al. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics. 2007, 6(1), 141-149.
[55]Liu T, Qian WJ, Gritsenko MA, et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005, 4(6), 2070-2080.
[56]Frantzen F, Grimsrud K, Heggli DE,et al. Protein-boronic acid conjugates and their binding to low-molecular-mass cis-diols and glycated hemoglobin. J Chromatogr B. 670, 37-45.
[57]Sparbier K, Koch S, Kessler I, et al. Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles.J Biomol Tech.2005, 16(4), 407-413.
[58]Sparbier K, Asperger A, Resemann A, et al. Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection.J Biomol Tech.2007,18(4), 252-258.
[59]Xu Y, Wu Z, Zhang L, et al. Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica.Anal Chem, 2009,81, 503-508.
[60]An HJ, Peavy TR, Hedrick JL, et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins.Anal Chem. 2003,75(20), 5628-5637.
[61]Wada Y, Tajiri M, Yoshida S. Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics.Anal Chem.2004, 76(22),6560-6565.
[62]H?gglund P, Bunkenborg J, Elortza F,et al. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res. 2004, 3(3), 556-566.
[63]Takegawa Y, Deguchi K, Ito H,et al. Simple separation of isomeric sialylated N-glycopeptides by a zwitterionic type of hydrophilic interaction chromatography. J Sep Sci , 2006, 29(16),2533-2540.
[64]Alvarez-Manilla G, AtwoodⅢ, Guo Y, et al. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides withN-linked glycosylation sites. J Proteome Res. 2006, 5(3),701-708.
[65]Wei Jia, Zhuang Lu, Yan Fu, et al. A Strategy for Precise and Large-Scale Identification of Core Fucosylated Glycoproteins. Mol Cell Proteomics. 2009, 8, 913-923
[66]Hitchen PG, Dell A. Bacterial glycoproteomics. Microbiology. 2006, 152(Pt6), 1575-1580.
[67]Aas FE, Egge-Jacobsen W, Winther-Larsen, et al. Neisseria gonorrhoeae type IV pili undergo multisite, hierarchical modifications with phosphoethanolamine and phosphocholine requiring an enzyme structurally related to lipopolysaccharide phosphoethanolamine transferases. J. Biol. Chem. 2006,281(38), 27712-27723.
[68] Twine, S.M. Paul CJ, Vinogradov E,et al. Flagellar glycosylation in Clostridium botulinum. FEBS J. 2008,275(17), 4428-4444.
[69]Hakansson K, Chalmers MJ, Quinn JP, et al. Combined electron capture and infrared multiphoton dissociation for multistage MS/MS in a Fourier transform ion cyclotron resonance mass spectrometer. Anal. Chem. 2003,75(13), 3256-3262.
[70]Hakansson K, Cooper HJ, Emmett MR, et a.Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information.Anal. Chem. 2001,73(18),4530-4536.
[71]Hogan JM, Pitteri SJ, Chrisman PA, et al. Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation.J. Proteome Res. 2005, 4(2),628-632.
[72]Krishnamoorthy L, Bess JW Jr, Preston AB, et al. HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin.Nat Chem Biol.2009, 5(4),244-250.
[73]Li C, Simeone DM, Brenner DE, et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res. 2009,8 (2),483-492.
[74]Meany DL, Zhang Z, Sokoll LJ, et al. Glycoproteomicsfor prostate cancer detection: Changes in serum PSA glycosylation patterns. J Proteome Res, 2009, 8(2), 613-619.
[75]Chen SM, LaRoche T, Hamelinck D, et al. Multiplexed analysis of glycan variation onnative proteins captured by antibody microarrays. Nat Methods.2007,4(5),437-444.
[76]Gornik O, Lauc G, Enzyme linked lectin assay (ELLA) for direct analysis of transferrin sialylation in serum samples. Clin Biochem. 2007,40(9-10),718-723.
[77]Zhao J, Qiu WL, Simeone DM, et al. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J Proteome Res. 2007, 6(3),1126-1138.
[78]Qiu YH, Patwa TH, Xu L, et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res. 2008,7(4),1693-1703.
[79]Chen R, Jiang X, Sun D, et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009,8(2),651-61.
[80]An HJ, Peavy TR, Hedrick JL, et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal Chem. 2003,75(20), 5628-5637.
[81]Clowers BH, Dodds ED, Seipert RR, et al. Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res. 2007,6(10),4032-4040.
[82]Juhasz P, Martin SA. The utility of nonspecific proteases in the characterization of glycoproteins by high-resolution time-of-flight mass spectrometry. J Mass Spectrom Ion Process.1997,169,217-230.
[83]Temporini C, Perani E, Calleri E, et al. Pronase-immobilized enzyme reactor: an approach for automation in glycoprotein analysis by LC/LC-ESI/MSn. Anal Chem. 2007,79(1),355-363.
[84]Yu YQ, Fournier J, Gilar M, e. al. Identification of N-linked glycosylation sites using glycoprotein digestion with pronase prior to MALDI tandem time-of-flight mass spectrometry. Anal Chem. 2007,79(4),1731-1738.
[85]Dodds ED, Seipert RR, Clowers BH, et al. Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics. J Proteome Res. 2009,8(2),502-512.
[86]Patel TP, Parekh RB, Release of oligosaccharides from glycoproteins by hydrazinolysis. Methods in Enzymology, 1994, 230, 57-66.
[87]Morelle W, Strecker G, Structural analysis of a new series of oligosaccharide- alditols released by reductive beta elimination from oviducal mucins of Rana utricularia. Biochemical Journal, 1998, 330, 469-478.
[88]Geert Jan Rademaker Spiros A, Pergantis, Leonore Blok-Tip, et al. Mass Spectrometric Determination of the sites of O-glycan attachment with low picomolarsensitivity. Anal Biochem. 1998, 257(2), 149-160
[89]Huang Y, Mechref Y, Novotny MV. Microscale non-reductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem, 2001,73(24), 6063-6069.
[90]Müller S, Goletz S, Packer N,et al.Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo. J Biol Chem. 1997,272(40),24780-24793.
[91]Gerken TA, Owens CL, Pasumarthy M. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site. J Biol Chem. 1997,272(15),9709-9719.
[92]Gerken TA, Gupta R, Jentoft N. A novel approach for chemically deglycosylating O-linked glycoproteins. The deglycosylation of submaxillary and respiratory mucins. Biochemistry. 1992,31(3),639-648.
[93]Hong JC, Kim YS, Alkali-catalyzed beta-elimination of periodate-oxidzsed glycans: A novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections. Glycoconj J.. 2000,17(10), 691-703.
[94]Hanisch FG, Teitz S, Schwientek T, et al. Chemical de-O-glycosylation of glycoproteins for application in LC-based proteomics. Proteomics. 2009, 9, 710-719.
[95]Tretter V, Altmann F, Marz L, Peptide-N4-(N-acetyl-b-glucosaminyl) asparagine amidase F cannot release glycans with fucose attached a1–3 to the asparagine linked N-acetylglucosamine residue. Eur. J. Biochem. 1991,199, 647-652
[96]H?gglund P, Matthiesen R, Elortza F, et al. An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J Proteome Res. 2007, 6(8),3021-3031.
[97]Bigge JC, Patel TP, Bruce JA,et al. Nonselective and efficientfluorescent labeling of glycans using 2-amino benzamide andanthranilic acid. Anal Biochem. 1995, 230, 229-238.
[98]Zhuang Z, Starkey JA, Mechref Y, et al.Electrophoretic analysis of N-glycans onmicrofluidic devices. Anal Chem. 79(18), 7170-7175.
[99]Anumula KR, Unique anthranilic acid chemistryfacilitates profiling and characterization of Ser/Thr-linked sugarchains following hydrazinolysis. Anal Biochem.2008, 373,104-111.
[100]Rudd PM, Guile GR, Kuster B, et al. Oligosaccharide sequencing technology. Nature. 1997, 388, 205-207.
[101]Guile GR, Wong SYC, Dwek RA, Analytical and preparative separation of anionic oligosaccharides by weak anion exchange high performance liquid chromatography on an inert polymer column. Anal Biochem. 1994, 222(1), 231-235.
[102]Nakajima K, OdaY, Kinoshita M,et al. Capillary affinity electrophoresis for the screening of posttranslational modification of protein with carbohydrates. J Proteome Res. 2003,2(1), 81-88.
[103]Powell AK, Harvey DJ, Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 1996, 10(9), 1027-1032.
[104]Ciucanu I, Kerek F, A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res. 1984,131, 209-217.
[105]Albersheim P, Nevins DJ, English PD,et al. A method for the analysis of sugars in plant cell wall polysaccharides by gas-liquid chromatography. Carbohydr Res. 1967,5, 340-345.
[106]Geyer R, Geyer H, Saccharide linkage analysis using methylation and other techniques. Methods Enzymol. 1994,230, 86-108 .
[107]Hellerqvist CG, Linkage analysis using Lindberg method. Methods Enzymol. 1990,193,554-573.
[108]Wuhrer M, Hokke CH, Deelder AM, Glycopeptide analysis by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry reveals novel features of horseradish peroxidase glycosylation.Rapid Commun Mass Spectrom. 2004, 18(15), 1741-1748.
[109]Petra O, Chen Wb, Asish B, Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2008, 22(1),29–40
[110]Vocadio DJ, Hang HC, Kim EJ, et al. A chemical approach for identifying O-GlcNAc modified proteins in cells. Proc Natl Acad Sci U S A.2004,100(6), 9116–9121.
[111]Saxon E, Bertozzi CR, Cell surface engineering by a modified Staudinger reaction. Science, 2000,287(5460), 2007-2010.
[112]Hang HC, Yu C, Kato DL,et al. A metabolic labelling approach towardproteomic analysis of mucin type O-linked glycosylation. Proc Natl Acad Sci U S A. 2003,100(25),14846-14851.
[113]Prescher JA, Dube DH, Bertozzi CR,Chemical remodelling of cell surfaces in living animals. Nature, 2004,430(7002), 873-877.
[114]Dube DH, Prescher JA, Quang CN, et al. Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci U S A. 2006,103(13), 4819-4824.
[115]Liu T, Qian WJ, Gritsenko MA, et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005,4(6), 2070-2080.
[116]Cao J, Shen C, Wang H, et al. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. J Proteome Res. 2009,8(2),662-672.
[117] Soltermann A, Ossola R, Kilgus-Hawelski S, et al. N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer. 2008, 114(2),124-133.
[118] Whelan SA, Lu M, He J, et al. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res. 2009,8(8),4151-4160.
[119]Chen R, Jiang X, Sun D, et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009,8(2),651-661.
[120]Kaji H, Saito H, Yamauchi Y, et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol. 2003,21(6),667-672.
[121] Barinka C, Sácha P, Sklenár J, et al. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein Sci. 2004 , 13(6),1627-1635.
[122]Kaji H, Yamauchi Y, Takahashi N, et al. Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging. Nat Protoc. 2006, 1(6),3019-3027.
[123]Atwood JA 3rd, Minning T, Ludolf F, et al. Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. J Proteome Res. 2006, 5(12),3376-3384.
[124]H?gglund P, Matthiesen R, Elortza F, et al. An enzymatic deglycosylationscheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J Proteome Res. 2007, 6(8),3021-3031.
[125]Liu Z, Cao J, He Y, et al. Tandem 18O stable isotope labeling for quantification of N-glycoproteome. J Proteome Res. 2010, 9(1),227-236.
[126]Angel PM, Lim JM, Wells L, et al. A potential pitfall in 18O-based N-linked glycosylation site mapping. Rapid Commun Mass Spectrom. 2007, 21(5),674-682.
[127]Morelle W, Donadio S, Ronin C, et al. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20(3),331-345.
[128] Jones AJ, Papac DI, Chin EH, et al. Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. Glycobiology. 2007, 17(5),529-40.
[129] Baker KN, Rendall MH, Hills AE,et al. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng. 2001,73(3), 188-202.
[130]Silva JC, Denny R, Dorschel C, et al. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol. Cell. Proteomics. 2006, 5(4), 589-607.
[131]Silva JC, Denny R, Dorschel CA, et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 2005, 77(7), 2187-2200.
[132]Silva JC, Gorenstein MV, Li GZ, et al. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.Mol. Cell. Proteomics 2006, 5(1), 144-156.
[133]Chakraborty AB, Berger SJ, Gebler JC, et al. Use of an integrated MS--multiplexed MS/MS data acquisition strategy for high-coverage peptide mapping studies.Rapid Commun. Mass Spectrom. 2007, 21(5), 730-744.
[134]Geromanos SJ, Vissers JP, Silva JC, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics. 2009, 9(6),1683-1695.
[135]Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3(4), 311-326.
[136]Xie H, Gilar M, Gebler JC. Characterization of protein impurities and site- specific modifications using peptide mapping with liquid chromatography and dataindependent acquisition mass spectrometry. Anal Chem. 2009, 81(14):5699-5708.
[137]Huddleston MJ, Bean MF, Carr SA. Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. Anal Chem. 1993,65(7),877-884.
[138]Schindler PA, Settineri CA, Collet X, et al. Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion. Protein Sci. 1995,4(4),791-803.
[139]Jebanathirajah J, Steen H, Roepstorff P. Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J Am Soc Mass Spectrom. 2003, 14(7),777-784.
[140] Thaysen-Andersen M, Mysling S, H?jrup P. Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. Anal Chem. 2009, 81(10), 3933-3943.
[141]Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 1998, 140(2), 431–446.
[142]Bajorath J, Greenfield B, Munro SB, et al. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J Biol Chem. 1998,273(1):338-43.
[143] Teriete P, Banerji S, Noble M, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell. 2004,13(4):483-96.
[144]James DC, Freedman RB, Hoare M, et al. N-glycosylation of recombinant human interferon-gamma produced in different animalexpression systems. BioTechnology. 1995,13,592–596.
[145]Lifely MR, Hale C, Boyce S, et al. Glycosylation and biological activity of Campath-1H expressed in different cell-lines and grown under different culture conditions. Glycobiology.1995,5,813–822.
[146]Jenkins N, Parekh RB, James DC. Getting the glycosylation right: Implications for the biotechnology industry. Nature Biotechnol.1996,14,975–981.
[147]Sheeley DM, Merrill BM, Taylor LCE. Characterization of monoclonal antibody glycosylation: Comparison of expression systems and identification of terminal alpha-linked galactose. Anal Biochem,1997, 247,102–110.
[148]Lavecchio JA, Dunne AD, Edge ASB. Enzymatic removal of alphagalactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation.1995,60, 841–847.
[149]Noguchi A, Mukuria CJ, Suzuki E et al. Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinanthuman erythropoietin expressed in Chinese hamster ovary cells. J Biochem, 1995,117,59–62.
[150]Muchmore EA, Milewski M, Varki A, et al. Biosynthesis of N- glycolyneuraminic acid—the primary site of hydroxylation of Nacetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem. 1989, 264:20216–20223.
[151]Irie A, Suzuki A. CMP-N-acetylneuraminic hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun.1998,248,330–333.
[152]Helenius A,Aebi M. Intracellular functions of N-linked glycans. Science,2001,291(5512), 2364-2369
[153]Lowe JB. Glycosylation, immunity, and autoimmunity.Cell, 2001, 104(6), 809-812
[154]Harvey DJ. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom. Rev. 1999, 18(6),349-450
[155]Dell A,Morris HR, Glycoprotein structure determination by mass spectrometry. Science, 2001, 291(5512), 2351-2356.
[156]Okamoto M , Takahashi K , Doi T, Sensitive detection and structural characterization of trimethyl(p-aminophenyl)-ammonium-derivatized oligosaccharide by electrospray ionization-mass spectrometry and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 1995, 9(8), 641-643
[157]Naven TJP,Harvey DJ, Thermal decomposition kinetics of protonated peptides and peptide dimers, and comparison with surface-induced dissociation. Rapid Commun. Mass Spectrom. 1996,10(7), 829-834
[158]Shinohara Y, Furukawa J, Niikura K,et al. Direct N-glycan profiling in the presence of tryptic peptides on MALDI-TOF by controlled ion enhancement and suppression upon glycan-selective derivatization. Anal. Chem. 2004, 76(23), 6989- 6997
[159]Kratzer R,Eckerskorn C,Karas M,et al. Suppression effects in enzymatic peptide ladder sequencing using ultraviolet - matrix assisted laser desorption/ionization - mass spectormetry. Electrophoresis, 1998, 19(11), 1910-1919
[160]LattováE,KapkováP, Krokhin O,et al. Method for investigation ofoligosaccharides from glycopeptides: direct determination of glycosylation sites in proteins.Anal Chem. 2006, 78(9), 2977-2984
[161]LattováE,Chen VC,Varma S,et al. Matrix-assisted laser desorption/ionization on-target method for the investigation of oligosaccharides and glycosylation sites in glycopeptides and glycoproteins. Rapid Commun. Mass Spectrom. 2007, 21(10), 1644-1650
[162]Zhang Y, Iwamoto T, Radke G, et al. On-target derivatization of keratan sulfate oligosaccharides with pyrenebutyric acid hydrazide for MALDI-TOF/TOF-MS. J. Mass Spectrom. 2008, 43(6), 765-772
[163]Packer NH,Lawson MA,Jardine DR,et al. A general approach to desalting oligosaccharides released from glycoproteins.Glycoconj J. 1998, 15(8),737-747
[164]Shinohara Y, Sota H, Kim F,et al. Use of a biosensor based on surface plasmon resonance and biotinyl glycans for analysis of sugar binding specificities of lectins. J. Biochem. 1995, 117(5), 1076-1082
[165]Hull SR, Turco SJ, Separation of dansyl hydrazine-derivatized oligosaccharides by liquid chromatography.Anal. Biochem. 1985, 146(1), 143-149
[166]Kameyama A, Kaneda Y, Yamanaka H,et al. Detection of oligosaccharides labeled with cyanine dyes using matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 2004, 76(15), 4537- 4542
[167]Zhang L, Zhang X,You MJ,et al. Analysis of neutral saccharides by high performance liquid chromatography after pre-column derivatization with 2-(9-carbazole)-ethoxycarbonyl hydrazide. Chinese J. Anal. Chem.2004, 32(8), 1002-1005
[168]Yet MG, Chin CC, Wold F, The covalent structure of individual N-linked glycopeptides from ovomucoid and asialofetuin. J. Biol. Chem. 1988, 263(1), 111-11
[2]Borland, G., Ross, J. A. & Guy, K. Forms and functions of CD44. Immunology 93, 139–148 (1998).
[3]Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003,4(1):33-45.
[4]Katoh S, Zheng Z, Oritani K. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995, 182(2), 419–429.
[5]Katoh S, Miyagi T, Taniguchi H, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol. 1999, 162(9), 5058-5061.
[6]Lesley J, English N, Perschl A, et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med. 1995, 182(2), 431-437.
[7]English NM, Lesley JF, Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 1998, 58(16), 3736-3742.
[8]Bartolazzi A, Nocks A, Aruffo A, Spring F, et al. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol. 1996 , 132(6),1199-1208.
[9] Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 1998, 140(2), 431–446.
[10]Dimitroff CJ, Lee JY, Fuhlbrigge RC, et al.A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S A. 2000, 97(25), 13841-13846.
[11]Hanley WD, Napier SL, Burdick MM, et al. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J. 2006, 20(2):337-9.
[12]Alves CS, Yakovlev S, Medved L,et al. Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J Biol Chem. 2009, 284(2), 1177-1189.
[13]Liu W, Tang L, Zhang G, et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem. 2004, 279(18),18748-18758.
[14]Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, et al. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood. 2007, 109(12), 5337-5345.
[15]Domínguez-Soto A, Aragoneses-Fenoll L, Gómez-Aguado F, et al. The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1.Hepatology, 2009, 49 (1), 287-296.
[16]Powlesland AS, Fisch T, Taylor ME, et al. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem. 2008, 283(1), 593-602.
[17] Gramberg T, Hofmann H, M?ller P, et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology. 2005, 340(2), 224-236.
[18] Tang L, Yang J, Tang X, et al. The DC-SIGN family member LSECtin is a novel ligand of CD44 on activated T cells. Eur J Immunol. 2010, 40(4), 1185-1191.
[19]Rudd PM. Oligosaccharides in human biology. Glyco News. 1993, 3, 1–8.
[20]Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta.1999, 1473(1), 4–8.
[21]Hagglund P, Bunkenborg J, Elortza F, et al. A new strategy for identification of I-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res.2004, 3(3), 556–566.
[22]Kameyama A, Nakaya S, Ito H, et al. Strategy for simulation of CID spectra of N-linked oligosaccharides towards glycomics. J Proteome Res.2006, 5, 808–814.
[23]Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007, 446, 1023–1029.
[24] Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006, 126, 855–867.
[25]Dall’Olio F. Protein glycosylation in cancer biology:an overview. Clin Mol Pathol. 1996, 49(3), M126–M135.
[26]Fukuda M. Possible roles of tumour associated carbohydrate antigens. Cancer Research. 1996, 56, 2237–2244.
[27]Brooks SA. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol Histopathol. 2000, 15, 143–158.
[28]Dube DH, Bertozzi CR. Glycans in cancer and inflammation–potential for therapeutics and diagnostics. Nat Rev Drug Discov. 2005, 4(6), 477–488.
[29]Van den Eijnden DH, Joziasse DH. Enzymes associated with glycosylation. Curr Opin Struct Biol. 1993, 3(5), 711–721.
[30]Dwek RA. Glycobiology: Toward the understanding of the function of sugars. Chemical Reviews. 1996, 96(2), 683–720.
[31]Joseph Zaia. Mass Spectrometry and the Emerging Field of Glycomics, Chem Biol. 2008,15(9), 881–892.
[32]Von der Lieth CW, Bohne-Lang A, Lohmann KK., et al. Bioinformatics for glycomics: status, methods, requirements and perspectives. Brief Bioinform. 2004, 5(2),164-178.
[33]Hirabayashi J, Hayama K, Kaji H, et al. Affinity capturing and gene assignment of soluble glycoproteins produced by the nematode Caenorhabditis elegansv. J Biochem (Tokyo). 2002, 132(1), 103-114.
[34]Dell A, Morris HR, Glycoprotein structure determination by mass spectrometry. Science. 2001, 291(5512), 2351-2356.
[35]Brooks SA, Hall DM, Buley I. GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane. Br J Cancer. 2001,85(7),1014-1022.
[36]Hart C, Schulenberg B, Steinberg TH, et al. Detection of glycoproteins in polyacrylamide gels and on electroblots using Pro-Q Emerald 488 dye, a fluorescent periodate Schiff-base stain. Electrophoresis. 2003, 24(4),588-598.
[37]Osborne C, Brooks SA. SDS-PAGE and Western blotting to detect proteins and glycoproteins of interest in breast cancer research. Methods Mol Med. 2006,120, 217-229.
[38]Wilson NL, Schulz BL, Karlsson NG, et al.Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res. 2002 ,1(6),521-529.
[39]Dwek MV, Rawlings SL. Current perspectives in cancer proteomics. Mol Biotechnol. 2002, 22(2),139-152.
[40]Dwek MV, Alaiya AA. Proteome analysis enables separate clustering of normalbreast, benign breast and breast cancer tissues. Br J Cancer, 2003, 89(2),305–307.
[41] Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005, 102(3), 779–784.
[42]Rudd PM, Colominas C, Royle L, et al. A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands. Proteomics. 2001, 1(2), 285–294.
[43] Rudiger H, Gabius HJ. Plant lectins: Occurrence, biochemistry, functions and applications. Glycoconj J.2001, 18(8), 589–613.
[44]Sharon N, Lis H. History of lectins: From hemagglutinins to biological recognition molecules. Glycobiology. 2004, 14(11), 53–62.
[45]Bunkenborg J, Pilch BJ, Podtelejnikov AV, et al. Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics. 2004, 4(2), 454-465.
[46]Hirabayashi J, Arata Y, Kasai K. Glycome project: concept, strategy and preliminary application to Caenorhabditis elegans. Proteomics. 2001, 1(2), 295-303.
[47]Hirabayashi J, Hashidate T, Kasai K. Glyco-catch method: A lectin affinity technique for glycoproteomics. J Biomol Tech. 2002, 13, 205-218.
[48]Hirabayashi J, Kasai K. Separation technologies for glycomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2002, 771(1-2), 67-87.
[49]Kaji H, Saito H, Yamauchi Y, et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol. 2003, 21(6), 667-672.
[50]Zhao J, Simeone DM, Heidt D, et al. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J Proteome Res. 2006, 5(7), 1792-1802.
[51]Kreunin P, Zhao J, Rosser C, et al. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res. 2007, 6(7), 2631-2639.
[52]Pan S, Wang Y, Quinn JF, et al. Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J Proteome Res. 2006, 5(10), 2769-2779.
[53]Lewandrowski U, Moebius J, Walter U, et al. Elucidation of N-glycosylation siteson human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics. 2006, 5(2), 226-233
[54]Sun B, Ranish JA, Utleg AG, et al. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics. 2007, 6(1), 141-149.
[55]Liu T, Qian WJ, Gritsenko MA, et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005, 4(6), 2070-2080.
[56]Frantzen F, Grimsrud K, Heggli DE,et al. Protein-boronic acid conjugates and their binding to low-molecular-mass cis-diols and glycated hemoglobin. J Chromatogr B. 670, 37-45.
[57]Sparbier K, Koch S, Kessler I, et al. Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles.J Biomol Tech.2005, 16(4), 407-413.
[58]Sparbier K, Asperger A, Resemann A, et al. Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection.J Biomol Tech.2007,18(4), 252-258.
[59]Xu Y, Wu Z, Zhang L, et al. Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica.Anal Chem, 2009,81, 503-508.
[60]An HJ, Peavy TR, Hedrick JL, et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins.Anal Chem. 2003,75(20), 5628-5637.
[61]Wada Y, Tajiri M, Yoshida S. Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics.Anal Chem.2004, 76(22),6560-6565.
[62]H?gglund P, Bunkenborg J, Elortza F,et al. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res. 2004, 3(3), 556-566.
[63]Takegawa Y, Deguchi K, Ito H,et al. Simple separation of isomeric sialylated N-glycopeptides by a zwitterionic type of hydrophilic interaction chromatography. J Sep Sci , 2006, 29(16),2533-2540.
[64]Alvarez-Manilla G, AtwoodⅢ, Guo Y, et al. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides withN-linked glycosylation sites. J Proteome Res. 2006, 5(3),701-708.
[65]Wei Jia, Zhuang Lu, Yan Fu, et al. A Strategy for Precise and Large-Scale Identification of Core Fucosylated Glycoproteins. Mol Cell Proteomics. 2009, 8, 913-923
[66]Hitchen PG, Dell A. Bacterial glycoproteomics. Microbiology. 2006, 152(Pt6), 1575-1580.
[67]Aas FE, Egge-Jacobsen W, Winther-Larsen, et al. Neisseria gonorrhoeae type IV pili undergo multisite, hierarchical modifications with phosphoethanolamine and phosphocholine requiring an enzyme structurally related to lipopolysaccharide phosphoethanolamine transferases. J. Biol. Chem. 2006,281(38), 27712-27723.
[68] Twine, S.M. Paul CJ, Vinogradov E,et al. Flagellar glycosylation in Clostridium botulinum. FEBS J. 2008,275(17), 4428-4444.
[69]Hakansson K, Chalmers MJ, Quinn JP, et al. Combined electron capture and infrared multiphoton dissociation for multistage MS/MS in a Fourier transform ion cyclotron resonance mass spectrometer. Anal. Chem. 2003,75(13), 3256-3262.
[70]Hakansson K, Cooper HJ, Emmett MR, et a.Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information.Anal. Chem. 2001,73(18),4530-4536.
[71]Hogan JM, Pitteri SJ, Chrisman PA, et al. Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation.J. Proteome Res. 2005, 4(2),628-632.
[72]Krishnamoorthy L, Bess JW Jr, Preston AB, et al. HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin.Nat Chem Biol.2009, 5(4),244-250.
[73]Li C, Simeone DM, Brenner DE, et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res. 2009,8 (2),483-492.
[74]Meany DL, Zhang Z, Sokoll LJ, et al. Glycoproteomicsfor prostate cancer detection: Changes in serum PSA glycosylation patterns. J Proteome Res, 2009, 8(2), 613-619.
[75]Chen SM, LaRoche T, Hamelinck D, et al. Multiplexed analysis of glycan variation onnative proteins captured by antibody microarrays. Nat Methods.2007,4(5),437-444.
[76]Gornik O, Lauc G, Enzyme linked lectin assay (ELLA) for direct analysis of transferrin sialylation in serum samples. Clin Biochem. 2007,40(9-10),718-723.
[77]Zhao J, Qiu WL, Simeone DM, et al. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J Proteome Res. 2007, 6(3),1126-1138.
[78]Qiu YH, Patwa TH, Xu L, et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res. 2008,7(4),1693-1703.
[79]Chen R, Jiang X, Sun D, et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009,8(2),651-61.
[80]An HJ, Peavy TR, Hedrick JL, et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal Chem. 2003,75(20), 5628-5637.
[81]Clowers BH, Dodds ED, Seipert RR, et al. Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res. 2007,6(10),4032-4040.
[82]Juhasz P, Martin SA. The utility of nonspecific proteases in the characterization of glycoproteins by high-resolution time-of-flight mass spectrometry. J Mass Spectrom Ion Process.1997,169,217-230.
[83]Temporini C, Perani E, Calleri E, et al. Pronase-immobilized enzyme reactor: an approach for automation in glycoprotein analysis by LC/LC-ESI/MSn. Anal Chem. 2007,79(1),355-363.
[84]Yu YQ, Fournier J, Gilar M, e. al. Identification of N-linked glycosylation sites using glycoprotein digestion with pronase prior to MALDI tandem time-of-flight mass spectrometry. Anal Chem. 2007,79(4),1731-1738.
[85]Dodds ED, Seipert RR, Clowers BH, et al. Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics. J Proteome Res. 2009,8(2),502-512.
[86]Patel TP, Parekh RB, Release of oligosaccharides from glycoproteins by hydrazinolysis. Methods in Enzymology, 1994, 230, 57-66.
[87]Morelle W, Strecker G, Structural analysis of a new series of oligosaccharide- alditols released by reductive beta elimination from oviducal mucins of Rana utricularia. Biochemical Journal, 1998, 330, 469-478.
[88]Geert Jan Rademaker Spiros A, Pergantis, Leonore Blok-Tip, et al. Mass Spectrometric Determination of the sites of O-glycan attachment with low picomolarsensitivity. Anal Biochem. 1998, 257(2), 149-160
[89]Huang Y, Mechref Y, Novotny MV. Microscale non-reductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem, 2001,73(24), 6063-6069.
[90]Müller S, Goletz S, Packer N,et al.Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo. J Biol Chem. 1997,272(40),24780-24793.
[91]Gerken TA, Owens CL, Pasumarthy M. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site. J Biol Chem. 1997,272(15),9709-9719.
[92]Gerken TA, Gupta R, Jentoft N. A novel approach for chemically deglycosylating O-linked glycoproteins. The deglycosylation of submaxillary and respiratory mucins. Biochemistry. 1992,31(3),639-648.
[93]Hong JC, Kim YS, Alkali-catalyzed beta-elimination of periodate-oxidzsed glycans: A novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections. Glycoconj J.. 2000,17(10), 691-703.
[94]Hanisch FG, Teitz S, Schwientek T, et al. Chemical de-O-glycosylation of glycoproteins for application in LC-based proteomics. Proteomics. 2009, 9, 710-719.
[95]Tretter V, Altmann F, Marz L, Peptide-N4-(N-acetyl-b-glucosaminyl) asparagine amidase F cannot release glycans with fucose attached a1–3 to the asparagine linked N-acetylglucosamine residue. Eur. J. Biochem. 1991,199, 647-652
[96]H?gglund P, Matthiesen R, Elortza F, et al. An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J Proteome Res. 2007, 6(8),3021-3031.
[97]Bigge JC, Patel TP, Bruce JA,et al. Nonselective and efficientfluorescent labeling of glycans using 2-amino benzamide andanthranilic acid. Anal Biochem. 1995, 230, 229-238.
[98]Zhuang Z, Starkey JA, Mechref Y, et al.Electrophoretic analysis of N-glycans onmicrofluidic devices. Anal Chem. 79(18), 7170-7175.
[99]Anumula KR, Unique anthranilic acid chemistryfacilitates profiling and characterization of Ser/Thr-linked sugarchains following hydrazinolysis. Anal Biochem.2008, 373,104-111.
[100]Rudd PM, Guile GR, Kuster B, et al. Oligosaccharide sequencing technology. Nature. 1997, 388, 205-207.
[101]Guile GR, Wong SYC, Dwek RA, Analytical and preparative separation of anionic oligosaccharides by weak anion exchange high performance liquid chromatography on an inert polymer column. Anal Biochem. 1994, 222(1), 231-235.
[102]Nakajima K, OdaY, Kinoshita M,et al. Capillary affinity electrophoresis for the screening of posttranslational modification of protein with carbohydrates. J Proteome Res. 2003,2(1), 81-88.
[103]Powell AK, Harvey DJ, Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 1996, 10(9), 1027-1032.
[104]Ciucanu I, Kerek F, A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res. 1984,131, 209-217.
[105]Albersheim P, Nevins DJ, English PD,et al. A method for the analysis of sugars in plant cell wall polysaccharides by gas-liquid chromatography. Carbohydr Res. 1967,5, 340-345.
[106]Geyer R, Geyer H, Saccharide linkage analysis using methylation and other techniques. Methods Enzymol. 1994,230, 86-108 .
[107]Hellerqvist CG, Linkage analysis using Lindberg method. Methods Enzymol. 1990,193,554-573.
[108]Wuhrer M, Hokke CH, Deelder AM, Glycopeptide analysis by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry reveals novel features of horseradish peroxidase glycosylation.Rapid Commun Mass Spectrom. 2004, 18(15), 1741-1748.
[109]Petra O, Chen Wb, Asish B, Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2008, 22(1),29–40
[110]Vocadio DJ, Hang HC, Kim EJ, et al. A chemical approach for identifying O-GlcNAc modified proteins in cells. Proc Natl Acad Sci U S A.2004,100(6), 9116–9121.
[111]Saxon E, Bertozzi CR, Cell surface engineering by a modified Staudinger reaction. Science, 2000,287(5460), 2007-2010.
[112]Hang HC, Yu C, Kato DL,et al. A metabolic labelling approach towardproteomic analysis of mucin type O-linked glycosylation. Proc Natl Acad Sci U S A. 2003,100(25),14846-14851.
[113]Prescher JA, Dube DH, Bertozzi CR,Chemical remodelling of cell surfaces in living animals. Nature, 2004,430(7002), 873-877.
[114]Dube DH, Prescher JA, Quang CN, et al. Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci U S A. 2006,103(13), 4819-4824.
[115]Liu T, Qian WJ, Gritsenko MA, et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005,4(6), 2070-2080.
[116]Cao J, Shen C, Wang H, et al. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. J Proteome Res. 2009,8(2),662-672.
[117] Soltermann A, Ossola R, Kilgus-Hawelski S, et al. N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer. 2008, 114(2),124-133.
[118] Whelan SA, Lu M, He J, et al. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res. 2009,8(8),4151-4160.
[119]Chen R, Jiang X, Sun D, et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009,8(2),651-661.
[120]Kaji H, Saito H, Yamauchi Y, et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol. 2003,21(6),667-672.
[121] Barinka C, Sácha P, Sklenár J, et al. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein Sci. 2004 , 13(6),1627-1635.
[122]Kaji H, Yamauchi Y, Takahashi N, et al. Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging. Nat Protoc. 2006, 1(6),3019-3027.
[123]Atwood JA 3rd, Minning T, Ludolf F, et al. Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. J Proteome Res. 2006, 5(12),3376-3384.
[124]H?gglund P, Matthiesen R, Elortza F, et al. An enzymatic deglycosylationscheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J Proteome Res. 2007, 6(8),3021-3031.
[125]Liu Z, Cao J, He Y, et al. Tandem 18O stable isotope labeling for quantification of N-glycoproteome. J Proteome Res. 2010, 9(1),227-236.
[126]Angel PM, Lim JM, Wells L, et al. A potential pitfall in 18O-based N-linked glycosylation site mapping. Rapid Commun Mass Spectrom. 2007, 21(5),674-682.
[127]Morelle W, Donadio S, Ronin C, et al. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20(3),331-345.
[128] Jones AJ, Papac DI, Chin EH, et al. Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. Glycobiology. 2007, 17(5),529-40.
[129] Baker KN, Rendall MH, Hills AE,et al. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng. 2001,73(3), 188-202.
[130]Silva JC, Denny R, Dorschel C, et al. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol. Cell. Proteomics. 2006, 5(4), 589-607.
[131]Silva JC, Denny R, Dorschel CA, et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 2005, 77(7), 2187-2200.
[132]Silva JC, Gorenstein MV, Li GZ, et al. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.Mol. Cell. Proteomics 2006, 5(1), 144-156.
[133]Chakraborty AB, Berger SJ, Gebler JC, et al. Use of an integrated MS--multiplexed MS/MS data acquisition strategy for high-coverage peptide mapping studies.Rapid Commun. Mass Spectrom. 2007, 21(5), 730-744.
[134]Geromanos SJ, Vissers JP, Silva JC, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics. 2009, 9(6),1683-1695.
[135]Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3(4), 311-326.
[136]Xie H, Gilar M, Gebler JC. Characterization of protein impurities and site- specific modifications using peptide mapping with liquid chromatography and dataindependent acquisition mass spectrometry. Anal Chem. 2009, 81(14):5699-5708.
[137]Huddleston MJ, Bean MF, Carr SA. Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. Anal Chem. 1993,65(7),877-884.
[138]Schindler PA, Settineri CA, Collet X, et al. Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion. Protein Sci. 1995,4(4),791-803.
[139]Jebanathirajah J, Steen H, Roepstorff P. Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J Am Soc Mass Spectrom. 2003, 14(7),777-784.
[140] Thaysen-Andersen M, Mysling S, H?jrup P. Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. Anal Chem. 2009, 81(10), 3933-3943.
[141]Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 1998, 140(2), 431–446.
[142]Bajorath J, Greenfield B, Munro SB, et al. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J Biol Chem. 1998,273(1):338-43.
[143] Teriete P, Banerji S, Noble M, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell. 2004,13(4):483-96.
[144]James DC, Freedman RB, Hoare M, et al. N-glycosylation of recombinant human interferon-gamma produced in different animalexpression systems. BioTechnology. 1995,13,592–596.
[145]Lifely MR, Hale C, Boyce S, et al. Glycosylation and biological activity of Campath-1H expressed in different cell-lines and grown under different culture conditions. Glycobiology.1995,5,813–822.
[146]Jenkins N, Parekh RB, James DC. Getting the glycosylation right: Implications for the biotechnology industry. Nature Biotechnol.1996,14,975–981.
[147]Sheeley DM, Merrill BM, Taylor LCE. Characterization of monoclonal antibody glycosylation: Comparison of expression systems and identification of terminal alpha-linked galactose. Anal Biochem,1997, 247,102–110.
[148]Lavecchio JA, Dunne AD, Edge ASB. Enzymatic removal of alphagalactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation.1995,60, 841–847.
[149]Noguchi A, Mukuria CJ, Suzuki E et al. Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinanthuman erythropoietin expressed in Chinese hamster ovary cells. J Biochem, 1995,117,59–62.
[150]Muchmore EA, Milewski M, Varki A, et al. Biosynthesis of N- glycolyneuraminic acid—the primary site of hydroxylation of Nacetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem. 1989, 264:20216–20223.
[151]Irie A, Suzuki A. CMP-N-acetylneuraminic hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun.1998,248,330–333.
[152]Helenius A,Aebi M. Intracellular functions of N-linked glycans. Science,2001,291(5512), 2364-2369
[153]Lowe JB. Glycosylation, immunity, and autoimmunity.Cell, 2001, 104(6), 809-812
[154]Harvey DJ. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom. Rev. 1999, 18(6),349-450
[155]Dell A,Morris HR, Glycoprotein structure determination by mass spectrometry. Science, 2001, 291(5512), 2351-2356.
[156]Okamoto M , Takahashi K , Doi T, Sensitive detection and structural characterization of trimethyl(p-aminophenyl)-ammonium-derivatized oligosaccharide by electrospray ionization-mass spectrometry and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 1995, 9(8), 641-643
[157]Naven TJP,Harvey DJ, Thermal decomposition kinetics of protonated peptides and peptide dimers, and comparison with surface-induced dissociation. Rapid Commun. Mass Spectrom. 1996,10(7), 829-834
[158]Shinohara Y, Furukawa J, Niikura K,et al. Direct N-glycan profiling in the presence of tryptic peptides on MALDI-TOF by controlled ion enhancement and suppression upon glycan-selective derivatization. Anal. Chem. 2004, 76(23), 6989- 6997
[159]Kratzer R,Eckerskorn C,Karas M,et al. Suppression effects in enzymatic peptide ladder sequencing using ultraviolet - matrix assisted laser desorption/ionization - mass spectormetry. Electrophoresis, 1998, 19(11), 1910-1919
[160]LattováE,KapkováP, Krokhin O,et al. Method for investigation ofoligosaccharides from glycopeptides: direct determination of glycosylation sites in proteins.Anal Chem. 2006, 78(9), 2977-2984
[161]LattováE,Chen VC,Varma S,et al. Matrix-assisted laser desorption/ionization on-target method for the investigation of oligosaccharides and glycosylation sites in glycopeptides and glycoproteins. Rapid Commun. Mass Spectrom. 2007, 21(10), 1644-1650
[162]Zhang Y, Iwamoto T, Radke G, et al. On-target derivatization of keratan sulfate oligosaccharides with pyrenebutyric acid hydrazide for MALDI-TOF/TOF-MS. J. Mass Spectrom. 2008, 43(6), 765-772
[163]Packer NH,Lawson MA,Jardine DR,et al. A general approach to desalting oligosaccharides released from glycoproteins.Glycoconj J. 1998, 15(8),737-747
[164]Shinohara Y, Sota H, Kim F,et al. Use of a biosensor based on surface plasmon resonance and biotinyl glycans for analysis of sugar binding specificities of lectins. J. Biochem. 1995, 117(5), 1076-1082
[165]Hull SR, Turco SJ, Separation of dansyl hydrazine-derivatized oligosaccharides by liquid chromatography.Anal. Biochem. 1985, 146(1), 143-149
[166]Kameyama A, Kaneda Y, Yamanaka H,et al. Detection of oligosaccharides labeled with cyanine dyes using matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 2004, 76(15), 4537- 4542
[167]Zhang L, Zhang X,You MJ,et al. Analysis of neutral saccharides by high performance liquid chromatography after pre-column derivatization with 2-(9-carbazole)-ethoxycarbonyl hydrazide. Chinese J. Anal. Chem.2004, 32(8), 1002-1005
[168]Yet MG, Chin CC, Wold F, The covalent structure of individual N-linked glycopeptides from ovomucoid and asialofetuin. J. Biol. Chem. 1988, 263(1), 111-11
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |